Prevalence of antiphospholipid antibodies in patients with subacute and chronic cutaneous lupus erythematosus;Prevalencia de anticuerpos antifosfolípido en pacientes con lupus eritematoso cutáneo subagudo y crónico

Actas Dermo-Sifiliograficas

Volumn 104, Issue 3, 2013, Pages 232-238

  Garcia Martin P ^a   Garcia Garcia C ^a   Fragab, J ^a   Garcia Diez A ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Chronic cutaneous lupus erythematosus; Subacute cutaneous lupus erythematosus; Systemic lupus erythematosus

Indexed keywords

ANTIBODY; ANTINUCLEAR ANTIBODY; BETA2 GLYCOPROTEIN ANTIBODY; CARDIOLIPIN ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL ARTICLE; FOLLOW UP; HUMAN; PREVALENCE; RETROSPECTIVE STUDY; SEROLOGY; SKIN LUPUS ERYTHEMATOSUS;

EID: 84876527280     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/j.ad.2012.10.017     Document Type: Article

References (21)

1. García-García C. Anticuerpos antifosfolípido y síndrome antifosfolípido: actitudes diagnósticas y terapéuticas. Actas Dermosifiliogr. 2007;98: 16-23.
2. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4: 295-306.
3. Gezer S. Antiphospholipid syndrome. Dis Mon. 2003;49: 696-741.
4. Petri M. Update on anti-phospholipid antibodies in SLE: the Hopkins' Lupus Cohort. Lupus. 2010;19: 419-23.
5. Cervera R, Asherson RA. Clinical and epidemiological aspects in the antiphospholipid syndrome. Immunobiology. 2003;207: 5-11.
6. Leroy V, Arvieux J, Jacob MC, Maynard-Muet M, Baud M, Zarski JP. Prevalence and significance of anticardiolipin, anti-beta2 glycoprotein i and anti-prothrombin antibodies in chronic hepatitis C. Br J Hematol. 1998;101: 468-74.
7. Triplett DA. Many faces of lupus anticoagulants. Lupus. 1998;7:S18-22.
8. McMahon MA, Keogan M, O'Connell P, Kearns G. The prevalence of antiphospholipid antibody syndrome among systemic lupus erythematosus patients. Ir Med J. 2006;99: 296-8.
9. Tarr T, Lakos G, Bhattoa HP, Soltesz P, Shoenfeld Y, Szegedi G, et al. Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up. Clin Rev Allergy Immunol. 2007;32: 131-7.
10. Tebbe B, Orfanos CE. Anticardiolipin-Antikörper beim kutanen lupus erythematodes. Hautarzt. 1992;43: 130-3.
11. Kind P, Schuppe HC, Jung KP, Degitz K, Lakomek HJ, Goerz G. Kutaner lupus erythematodes und kardiolipin-antikörper. Hautzarzt. 1992;43: 126-9.
12. Fonseca E, Alvarez R, González MR, Pascual D. Prevalence of anticardiolipin antibodies in subacute cutaneous lupus erythematosus. Lupus. 1992;1: 265-8.
13. Ruffatti A, Veller-Fornasa C, Patrassi GM, Sartori E, Tonello M, Tonetto S, et al. Anticardiolipin antibodies and antiphospholipid syndrome in chronic discoid lupus erythematosus. Clin Rheumatol. 1995;14: 402-4.
14. Gilliam JN, Sontheimer RD. Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol. 1981;4: 471-5.
15. Walling HW, Sontheimer RD. Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am J Clin Dermatol. 2009;10: 365-81.
16. Albrecht J, Taylor L, Berlin JA, Dulay S, Ang G, Fakharzadeh S, et al. The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus. J Invest Dermatol. 2005;125: 889-94.
17. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25: 1271-7.
18. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthrititis Rheum. 1997;40: 1725.
19. Meuth AM, Amler S, Haust M, Bein D, Sauerland C, Köpcke W, et al. A database analysis of cutaneous lupus erythematosus with the EUSCLE Core Set Questionnaire. Acta Derm Venereol. 2010;90: 386-94.
20. Mayou SC, Wojnarowska F, Lovell CR, Asherson RA, Leigh IM. Anticardiolipin and antinuclear antibodies in discoid lupus erythematosus- their clinical significance. Clin Exp Dermatol. 1988;13: 389-92.
21. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Eng J Med. 2002;346: 752-63.